Medication info
Dapagliflozin 5 mg (Dapagliflozin Bisl-Proline)

Dapagliflozin 5 mg (Dapagliflozin Bisl-Proline)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Bis L-proline›7.815mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Yellow, round, biconvex film-coated tablets
Packaging
For domestic use - 30 tablets/bottle
Approval status
Active

MFDS item code 202402722 · Approved 2024.11.19 · Insurance code 648105110

Summary

Main use
Improvement of blood glucose in type 2 diabetes, and reduction of the risk of chronic heart failure and chronic kidney disease
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Under 18 years of age: The efficacy and safety of dapagliflozin in pediatric patients under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose in type 2 diabetes, and reduction of the risk of chronic heart failure and chronic kidney disease

  • Type 2 diabetes
  • impaired blood sugar control
  • cardiovascular disease
  • cardiovascular risk factors
  • chronic heart failure
  • heart failure
  • chronic kidney disease
  • estimated glomerular filtration rate decline
  • end-stage renal disease
View approved original text

This medication is used in conjunction with diet and exercise to help regulate blood sugar in patients with type 2 diabetes. It can be administered alone or in combination with other medications if blood sugar control is insufficient. Additionally, it is effective for patients with cardiovascular disease risk or existing cardiovascular conditions. For patients with chronic heart failure, it is used alongside other standard treatments to reduce the risk of death and hospitalizations due to heart failure. In patients with chronic kidney disease, it is combined with standard treatments to help reduce the deterioration of kidney function and cardiovascular risk. Overall, this medication plays a key role in preventing and treating complications of diabetes, heart failure, and kidney disease.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Under 18 years of age: The efficacy and safety of dapagliflozin in pediatric patients under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be administered to certain patients. For example, patients who are allergic to the active ingredient or excipients of this medication, patients with type 1 diabetes, diabetic ketoacidosis patients, patients with lactose intolerance or certain genetic conditions, and patients undergoing dialysis should not use it. Caution is advised when administering this medication to patients with reduced fluid volume or poor kidney function. It can lower blood pressure or affect kidney function, increasing the risk of hypotension, particularly in elderly patients or those taking diuretics. Therefore, careful assessment and monitoring of fluid status and kidney function should be conducted before and after administration. The most common side effects during treatment with this medication may include genital infections. Symptoms such as urinary tract infections, hypoglycemia, decreased fluid volume, dizziness, thirst, constipation, and back pain may also occur. Particularly, severe metabolic abnormalities such as diabetic ketoacidosis may occur; immediately consult healthcare professionals if symptoms such as dehydration, vomiting, abdominal pain, or difficulty breathing appear while taking this medication. This medication may interact with other drugs; caution is required particularly when taken with diuretics, insulin, or sulfonylureas, as the risk of hypoglycemia or dehydration may increase. Pregnant or breastfeeding women are advised not to use this medication, and its safety and efficacy in pediatric patients have not been established. There is no specific antidote for overdose; therefore, it is important to receive appropriate treatment based on the symptoms. While taking this medication, there are no impairments reported for driving or operating machinery, but caution is advised for hypoglycemic symptoms when taken in combination with insulin or sulfonylureas. Finally, this medication should be stored in its original container and kept out of reach of children.

Side effects

Vulvar vaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, reduced fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, reduced renal creatinine clearance early in treatment, dyslipidemia, elevated blood creatinine early in treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, urosepsis, pyelonephritis, acute kidney damage, renal dysfunction, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylaxis, paresthesia, cerebral infarction, nerve compression, sensory loss, headache, nasopharyngitis, upper respiratory tract infection, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, chest pain, fatigue, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularity, pruritus, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, hair loss, dermatitis, skin xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcers, excessive sweating dermatitis, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, decreased appetite, somnolence, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disturbances, syncope, tremor, bronchitis, herpes zoster, tonsillitis, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularity, genital edema, vulvar discomfort, hair loss, dermatitis, skin xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcers, excessive sweating dermatitis, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, diaphoresis, dermatitis, skin xerosis, hyperkeratosis, skin lesions, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, contusion, road traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, pelvic fracture, laceration, ligament rupture, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibial fracture, dental injury, dry eye, ocular pain, retinal disorders, visual impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual disability, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, chronic obstructive disease, voice disorder, epistaxis, hemoptysis, sputum, sleep apnea syndrome, wheezing, arteriosclerosis, cerebral hemorrhage, flushing, peripheral artery occlusion, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, angina pectoris, atrial fibrillation, diastolic dysfunction, myocardial infarction, anxiety disorder, nocturia, depression, auditory hallucination, sleep disturbances, suicide attempt, bile duct stones, cholangitis, alcoholic cirrhosis, liver cysts, dizziness, gastric adenocarcinoma, anal genital warts, adenoma, neuroma, unspecified pituitary neoplasm, male reproductive gland failure, thyroid cyst, thyroid mass, anaphylactic reaction, food allergy, erythrocytosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees.

Appearance and packaging

Appearance

Yellow, round, biconvex film-coated tablets

Package unit

For domestic use - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.